Lanean...

PS2-35: Variation in Capture of Chemotherapy Data: Preliminary Findings From the CRN Economic Rx Burden Pilot Study

Background: A number of high-cost chemotherapy agents, including targeted biologic and genetic therapies, have been introduced to the U.S. in recent years. Much of the literature on use and costs of these new agents has been derived from clinical trials and Medicare/SEER-based studies. To date, few...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ritzwoller, Debra P., Delate, Tom, Freml, Jared, Clarke, Addie, O’Keeffe-Rosetti, Maureen, Fishman, Paul, Bachman, Donald J., Lafata, Jennifer Elston, Hornbrook, Mark C.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Marshfield Clinic 2010
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2842390/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.8.1.35
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!